{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:15:06Z","timestamp":1767960906764,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.01.056","type":"journal-article","created":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T12:12:28Z","timestamp":1169640748000},"page":"3679-3683","source":"Crossref","is-referenced-by-count":25,"title":["Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Roland","family":"Grunow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Porsch-\u00d6zc\u00fcr\u00fcmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf","family":"Splettstoesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno","family":"Buckendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"vd Esche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Frangoulidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst-J\u00fcrgen","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2007.01.056_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0014-5793(02)03609-8","article-title":"Anthrax toxin: a tripartite lethal combination","volume":"531","author":"Ascenzi","year":"2002","journal-title":"FEBS Lett"},{"issue":"6946","key":"10.1016\/j.vaccine.2007.01.056_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","article-title":"Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin","volume":"424","author":"Agrawal","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vaccine.2007.01.056_bib3","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/IAI.68.10.5731-5734.2000","article-title":"Protective antigen-mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect Immun"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2007.01.056_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0264-410X(96)00286-1","article-title":"Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern","volume":"15","author":"Shlyakhov","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.056_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2672.1999.00898.x","article-title":"Immune correlates of protection against anthrax","volume":"87","author":"Fowler","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.01.056_bib6","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1128\/IAI.67.7.3290-3296.1999","article-title":"Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity","volume":"67","author":"Doling","year":"1999","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.01.056_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","article-title":"Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system","volume":"286","author":"Crotty","year":"2004","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.056_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the UK anthrax vaccine","volume":"42","author":"Baillie","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.056_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-2-5","article-title":"Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed","volume":"2","author":"Sawada-Hirai","year":"2004","journal-title":"J Immune Based Ther Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.056_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1472-765X.1998.00274.x","article-title":"Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis","volume":"26","author":"Miller","year":"1998","journal-title":"Lett Appl Microbiol"},{"issue":"18","key":"10.1016\/j.vaccine.2007.01.056_bib11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0264-410X(95)00139-R","article-title":"Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs","volume":"13","author":"Ivins","year":"1995","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2007.01.056_bib12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2007.01.056_bib13","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.056_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"19","key":"10.1016\/j.vaccine.2007.01.056_bib15","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.056_bib16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.01.056_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00189414","article-title":"Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"177","author":"Turnbull","year":"1988","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2007.01.056_bib18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin","volume":"20","author":"Gaur","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.01.056_bib19","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2007.01.056_bib20","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.056_bib21","first-page":"83","article-title":"Protective and other biological properties of Bacillus anthracis soluble antigens","volume":"35","author":"Abalakin","year":"1991","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2007.01.056_bib22","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1073\/pnas.0401351101","article-title":"mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia","volume":"101","author":"Kozel","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2007.01.056_bib23","first-page":"71","article-title":"Postinfection and postvaccinal antianthrax immunity in human subjects","volume":"6","author":"Abalakin","year":"1990","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.01.056_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2007.01.056_bib25","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.056_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect Immun"},{"issue":"32","key":"10.1016\/j.vaccine.2007.01.056_bib27","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.01.056_bib28","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2007.01.056_bib29","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0264-410X(02)00058-0","article-title":"Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.01.056_bib30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"Quinn","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T21:50:00Z","timestamp":1587333000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07000850"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}